Monitor for additional insider selling patterns; a single director sale of this size is not unusual but could signal reduced conviction. The filing does not indicate a lock-up expiry or earnings catalyst timing.
SEPN drugs
SEPN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $41.86entry
- T+1 · 4d ago +1.77%α +2.13% · $42.60
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Director Alan Ezekowitz filed a Form 144 to sell 100,000 shares of Septerna, Inc. with an estimated aggregate value of $5,234,000. The sale was executed on November 11, 2026, and is being reported on November 12 due to the Veterans Day holiday. This represents a notable insider sale by a director, amounting to approximately 0.21% of the company's $2.5B market cap.
Key Facts
- Insider: Alan Ezekowitz, Director
- Shares to be sold: 100,000 shares of common stock
- Estimated aggregate value: $5,234,000
- Sale executed on November 11, 2026; filing on November 12 due to federal holiday
- Shares acquired via open market purchases from March 4-7, 2025
- Market cap: $2.5B; sale represents ~0.21% of market cap
Financial Impact
Director selling $5.2M worth of shares, representing about 0.21% of market cap
Risk Factors
- Insider selling may indicate reduced confidence in near-term prospects
- Form 144 is an intent to sell; actual sale may not occur
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010978 |
| Document: 0001950047-26-010978-index.html | 0001950047-26-010978 |
| Document: 0001950047-26-010978.txt | 0001950047-26-010978 |
Track record
25 reports on SEPN
7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 3/10 Viewing Entry $41.86 Now $41.67 −0.45% settles Nov 19
- Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
- Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
- Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers